SIMPLEX TRADING, LLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$0553
+2972.2%
0.00%
Q1 2023$018
-76.9%
0.00%
Q3 2022$0
-100.0%
78
-97.7%
0.00%
Q2 2022$22,000
+15.8%
3,378
-13.7%
0.00%
Q1 2022$19,000
+58.3%
3,913
+138.9%
0.00%
Q4 2021$12,0001,6380.00%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$69,963,29235.72%
Orland Properties Ltd 15,093,969$52,376,07227.91%
Foresite Capital Management IV, LLC 10,000,000$34,700,00014.82%
MIC Capital Management UK LLP 3,060,569$10,620,1742.10%
Alphabet Inc. 5,865,125$20,351,9841.18%
HSG Holding Ltd 3,045,997$10,569,6101.07%
Artal Group S.A. 700,000$2,4290.14%
Eagle Health Investments LP 100,000$347,0000.08%
Virtus ETF Advisers LLC 39,345$136,5270.07%
BBR PARTNERS, LLC 164,041$569,2220.06%
View complete list of LYELL IMMUNOPHARMA INC shareholders